$21.38
0.110.52%
In chiusura: -
$21.44
0.060.28%
After hour: Oct 31, 4:35 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Pacira BioSciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 6
Stima EPS
$0.560
Stima dei ricavi trimestrali
$182.38M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$705.85M
Analizza lo storico degli utili di Pacira BioSciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PCRX | Pacira BioSciences | $0.79 | $0.56 | — | — | $168.57M | $182.38M | — | — | 11/06/2025 | |
PCRX | Pacira BioSciences | $0.89 | $0.62 | $0.74 | 19.35% | $178.02M | $183.35M | $181.10M | -1.23% | 08/05/2025 | |
PCRX | Pacira BioSciences | $0.62 | $0.60 | $0.62 | 3.33% | $167.12M | $175.88M | $168.92M | -3.96% | 05/08/2025 | |
PCRX | Pacira BioSciences | $0.89 | $0.83 | $0.91 | 9.64% | $181.24M | $185.38M | $187.25M | 1.01% | 02/27/2025 | |
PCRX | Pacira BioSciences | $0.72 | $0.70 | $0.79 | 12.86% | $163.93M | $169.67M | $168.57M | -0.65% | 11/06/2024 | |
PCRX | Pacira BioSciences | $0.78 | $0.70 | $0.89 | 27.14% | $169.47M | $172.48M | $178.02M | 3.21% | 07/30/2024 | |
PCRX | Pacira BioSciences | $0.53 | $0.62 | $0.62 | 0.00% | $160.34M | $165.35M | $167.12M | 1.07% | 05/07/2024 | |
PCRX | Pacira BioSciences | $0.80 | $0.88 | $0.89 | 1.14% | $171.96M | $181.66M | $181.24M | -0.23% | 02/29/2024 | |
PCRX | Pacira BioSciences | $0.64 | $0.79 | $0.72 | -8.86% | $167.47M | $173.00M | $163.93M | -5.25% | 11/02/2023 | |
PCRX | Pacira BioSciences | $0.51 | $0.81 | $0.78 | -3.70% | $169.41M | $175.64M | $169.47M | -3.51% | 08/02/2023 | |
PCRX | Pacira BioSciences | $0.64 | $0.62 | $0.53 | -14.52% | $157.99M | $158.84M | $160.34M | 0.94% | 05/03/2023 | |
PCRX | Pacira BioSciences | $0.97 | $0.83 | $0.80 | -3.61% | $159.19M | $173.50M | $171.96M | -0.89% | 02/28/2023 | |
PCRX | Pacira BioSciences | $0.72 | $0.76 | $0.64 | -15.79% | $127.72M | $168.89M | $167.47M | -0.84% | 11/03/2022 | |
PCRX | Pacira BioSciences | $0.77 | $0.88 | $0.51 | -42.05% | $135.59M | $171.43M | $169.41M | -1.18% | 08/03/2022 | |
PCRX | Pacira BioSciences | $0.53 | $0.83 | $0.64 | -22.89% | $119.03M | $159.49M | $157.99M | -0.94% | 05/04/2022 | |
PCRX | Pacira BioSciences | $0.87 | $0.90 | $0.97 | 7.78% | $130.97M | $155.74M | $159.19M | 2.22% | 02/24/2022 | |
PCRX | Pacira BioSciences | $0.68 | $0.65 | $0.72 | 10.77% | $117.48M | $130.38M | $127.72M | -2.04% | 11/03/2021 | |
PCRX | Pacira BioSciences | $0.12 | $0.69 | $0.77 | 11.59% | $75.50M | $128.01M | $135.59M | 5.92% | 08/03/2021 | |
PCRX | Pacira BioSciences | $0.53 | $0.63 | $0.53 | -15.87% | $105.68M | $119.28M | $119.03M | -0.21% | 05/04/2021 | |
PCRX | Pacira BioSciences | $0.56 | $0.81 | $0.87 | 7.41% | $122.42M | $131.57M | $130.97M | -0.45% | 02/25/2021 |
Pacira BioSciences (PCRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $0.74 | $0.62 | 19.4 % |
| Q1 | 2025-05-08 | $0.62 | $0.60 | 3.33 % |
| Q4 | 2025-02-27 | $0.91 | $0.83 | 9.64 % |
| Q3 | 2024-11-06 | $0.79 | $0.70 | 12.9 % |
Pacira BioSciences (PCRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $181.10M | $183.35M | -1.23 % |
| Q1 | 2025-05-08 | $168.92M | $175.88M | -3.96 % |
| Q4 | 2025-02-27 | $187.25M | $185.38M | 1.01 % |
| Q3 | 2024-11-06 | $168.57M | $169.67M | -0.65 % |
FAQ
Quando Pacira BioSciences (NASDAQ:PCRX) riporterà gli utili?
Si prevede che Pacira BioSciences (PCRX) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Pacira BioSciences (NASDAQ:PCRX)?
L'EPS effettivo era $0.74, che superato la stima di $0.62.
Quali sono state le entrate di Pacira BioSciences (NASDAQ:PCRX)?
Le entrate effettive sono state $181.1M, che mancato la stima di $183.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.